Therapeutic Exploratory (Phase II)

3,454 trials 1,368 recruiting

Filter these 3,454 trials by condition, country, sponsor and more.

Open in Search →

A phase-2 clinical trial of regorafenib in patients with pretreated advanced melanoma Recruiting

2024-514087-11-02 Melanoma 2022-10-03
DK-CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19 positive hematological malignancies (DAN-CART 1901) Recruiting

2024-515174-27-00 Acute Lymphoblastic Leukemia and B-cell Non Hodgkin Lym 2022-10-03
TERTIO : Evaluation de l’intérêt de combiner un vaccin inducteur de CD4-Th1 dérivé de la télomérase avec un traitement par atezolizumab et b… Recruiting

2022-500643-20-00 Patients with locally advanced, metastatic or unresecta 2022-09-27
EVIDENT Recruiting

2023-510092-62-00 Colorectal cancer 2022-09-27
A study to Evaluate the Safety, the Tolerability, the Pharmacokinetics and the Activity of HM15136 administered in pediatric Patients with C… Recruiting

2024-515290-98-00 Congenital Hyperinsulinism (CHI) 2022-09-23
INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLAC… Recruiting

2024-517384-24-00 SCARRED VOCAL FOLDS 2022-09-22
DFIL2-REP - Study of the clinical and biological response to repeated administration of low-dose interleukin-2 in patients with type 1 diabe… Recruiting

2024-514043-29-00 Patient with newly diagnosed (≤ 3 months) type 1 diabet 2022-09-21
CPX-351 versus intensive chemotherapy in patients with de novo intermediate or adverse risk AML stratified by genomics Recruiting

2022-500295-60-00 Acute Myeloid Leukemia 2022-09-15
MetroWilms Recruiting

2022-502687-20-00 Wilms tumor 2022-09-14
Early detection of side effects in patients with metastatic melanoma receiving immune checkpoint inhibitor therapy by investigation of the C… Recruiting

2024-512219-37-00 melanoma 2022-09-06
Efficacy, Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With… Recruiting

2024-511382-11-00 Asthma 2022-08-29
Use of Imatinib to convert triple negative breast cancer into ER-positive breast cancer - I-CONIC Recruiting

2024-511141-19-00 Primary breast cancer 2022-08-22
HIsTological and CLinical effects of Imipramine in the treatment of patients with cancer over-expressing Fascin1. (HITCLIF) Recruiting

2023-504943-15-00 Cancer(colon cancer stage II-III, rectal cancer, and br 2022-08-19
Immunological variables associated to ICI toxicity in cancer patients Recruiting

2023-505360-11-00 solid tumour 2022-08-18
Monalizumab infusion in patients with acute myeloid leukemia or myelodysplastic syndrome undergoing haploidentical hematopoietic stem cell t… Recruiting

2024-516974-31-00 Patients with acute myeloid leukemia or myelodysplastic 2022-07-22
Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer,a randomized double-blind study with the possib… Recruiting

2024-517747-31-00 Depressive disorder comorbid with cancer 2022-07-22
Neuromyelitis Optica Spectrum Disorder Inebilizumab Study in Children and Adolescents Recruiting

2023-510007-22-00 Neuromyelitis optica spectrum disorder (NMOSD; also kno 2022-07-20
An Open Label, Phase 2 Study to Evaluate Activity and Safety of Daratumumab in combination with Bortezomib and Dexamethasone in patients wit… Recruiting

2024-511635-94-00 Relapsed or Refractory Plasmablastic lymphoma 2022-07-11
A study to evaluate efficacy and safety of an investigational drug named volixibat in patients with itching caused by primary biliary cholan… Recruiting

2023-504660-41-00 Cholestatic Pruritus in Patients with Primary Biliary C 2022-07-11
Inhalation therapy in adult bronchiectasis patients with new asymptomatic Pseudomonas aeruginosa infection– an open-label, proof of concept … Recruiting

2023-509277-22-00 Bronchiectasis 2022-06-22
Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting

2023-508852-21-00 Resectable, Early-stage (II to IIIB) Non-small Cell Lun 2022-06-10
A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight … Recruiting

2024-513168-24-00 HIV & Obesity 2022-06-01
Study of axitinib +/- pembrolizumab in first line treatment for patients with locally advanced or metastatic papillary renal cell carcinoma … Recruiting

2024-513986-38-00 Locally advanced or metastatic papillary cell carcinoma 2022-06-01
Sotorasib in advanced KRAS G12C-mutated non-small cell lung cancer patients with comorbidities (SOLUCOM) Recruiting

2023-503174-20-00 KRAS G12C-mutated non-small cell lung cancer 2022-05-30